do Carmo PHF, Garcia MT, Figueiredo-Godoi LMA, Lage ACP, da Silva NS, Junqueira JC
Disclosures: Chandler Shapiro: Nothing to Disclose, Sheena Gillani: Nothing to Disclose, Nancy Reau: Gilead: Grant/Research Support, eiger: Grant/Research Support, abbott: Consultant, Arbutus: Consultant, Gilead: Consultant, VIR: Consultant, Salix: Consultant, Salix: Grant/Research Support, AbbVie: Grant/Research Support, Samantha de los Reyes: Nothing to Disclose 489 IMPACT OF SUSTAINED VIROLOGICAL RESPONSE ON LONG-TERM OUTCOMES AFTER CURATIVE RESECTION IN PATIENTS WITH OF HEPATITIS-C-VIRUS-RELATED HEPATOCELLULAR CARCINOMA IN THE ERA OF DIRECT-ACTING ANTIVIRAL THERAPY Hayato Abe 1 Yukiyasu Okamura 1 , 1 Nihon University School of Medicine Background: There is controversy over the impact of sustained virologic response (SVR) for hepatitis C virus (HCV) infection on surgical outcomes for hepatocellular carcinoma (HCC) in the era of directacting antiviral (DAA) therapy

A growing body of research points to peptides, short chains of amino acids with highly specific biological activity, as some of the most promising molecules for supporting brain repair
Results and Discussion Structural studies Both the FhGST-S1 holoenzyme and the GSSG complex were crystallised in the same orthorhombic space group with slightly different unit cells (Table 1)